COMSovereign Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing and Further Stay

Stock Information for Nymox Pharmaceutical Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nymox Pharmaceutical Corporation

COMSovereign and Intelligent Waves Partner for Secure 5G, Drone Platforms and Software-as-a-Service Solutions Sales to the Government and DoD Markets
COMSovereign Regains Current Filer Status with Filing of 10-Qs for the Quarters Ended March 31, June 30, and September 30, 2023
COMSovereign Files 10-K For the Year Ended December 31, 2022
COMSovereign CTO Dr. Dustin McIntire to Lead 5G Architecture & Security Session at Cal Poly Pomona's National Science Foundation CyberCorps Program
COMSovereign's Fastback Intelligent Backhaul Radios Deployed at the Nation's Leading Travel Stop Network to Dramatically Improving Connectivity
COMSovereign Adds Wireless Network Monitoring and Compliance Software-as-a-Service Capability Through Reseller Agreement with SIFF.IO
COMSovereign Holding Corp. CEO David Knight to Present at the ThinkEquity Conference on October 19, 2023
COMSovereign Receives Notice from Nasdaq Regarding Delayed Quarterly Report

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.